These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

786 related articles for article (PubMed ID: 17803905)

  • 1. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts.
    Nakamura T; Imai Y; Matsumoto T; Sato S; Takeuchi K; Igarashi K; Harada Y; Azuma Y; Krust A; Yamamoto Y; Nishina H; Takeda S; Takayanagi H; Metzger D; Kanno J; Takaoka K; Martin TJ; Chambon P; Kato S
    Cell; 2007 Sep; 130(5):811-23. PubMed ID: 17803905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hormones and osteoporosis update. Estrogen and bone remodeling].
    Kato S
    Clin Calcium; 2009 Jul; 19(7):951-6. PubMed ID: 19567990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogens maintain bone mass by regulating expression of genes controlling function and life span in mature osteoclasts.
    Imai Y; Youn MY; Kondoh S; Nakamura T; Kouzmenko A; Matsumoto T; Takada I; Takaoka K; Kato S
    Ann N Y Acad Sci; 2009 Sep; 1173 Suppl 1():E31-9. PubMed ID: 19751412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and identification of estrogen receptor alpha co-regulators in osteoclasts.
    Takada I; Tsuji N; Youn MY; Fujiyama S; Okada M; Imai Y; Kondo S; Kitakawa H; Yasuda H; Kato S
    Ann N Y Acad Sci; 2010 Mar; 1192():201-7. PubMed ID: 20392237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of SERMs on bone health. Mechanisms of bone mass control by selective estrogen receptor modulator].
    Imai Y; Kato S
    Clin Calcium; 2010 Mar; 20(3):339-44. PubMed ID: 20190363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditional deletion of Bmpr1a in differentiated osteoclasts increases osteoblastic bone formation, increasing volume of remodeling bone in mice.
    Okamoto M; Murai J; Imai Y; Ikegami D; Kamiya N; Kato S; Mishina Y; Yoshikawa H; Tsumaki N
    J Bone Miner Res; 2011 Oct; 26(10):2511-22. PubMed ID: 21786321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of skin flap necrosis by estradiol involves reperfusion of a protected vascular network.
    Toutain CE; Brouchet L; Raymond-Letron I; Vicendo P; Bergès H; Favre J; Fouque MJ; Krust A; Schmitt AM; Chambon P; Gourdy P; Arnal JF; Lenfant F
    Circ Res; 2009 Jan; 104(2):245-54, 12p following 254. PubMed ID: 19059842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fas/FasL-mediated apoptosis in the arcuate nucleus and medial preoptic area of male ArKO mice is ameliorated by selective estrogen receptor alpha and estrogen receptor beta agonist treatment, respectively.
    Hill RA; Chow J; Fritzemeier K; Simpson ER; Boon WC
    Mol Cell Neurosci; 2007 Oct; 36(2):146-57. PubMed ID: 17716913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated turnover of metaphyseal trabecular bone in mice overexpressing cathepsin K.
    Kiviranta R; Morko J; Uusitalo H; Aro HT; Vuorio E; Rantakokko J
    J Bone Miner Res; 2001 Aug; 16(8):1444-52. PubMed ID: 11499867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat shock protein 60 causes osteoclastic bone resorption via toll-like receptor-2 in estrogen deficiency.
    Koh JM; Lee YS; Kim YS; Park SH; Lee SH; Kim HH; Lee MS; Lee KU; Kim GS
    Bone; 2009 Oct; 45(4):650-60. PubMed ID: 19527807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of apoptosis of human primary osteoclasts treated with a transcription factor decoy mimicking a promoter region of estrogen receptor alpha.
    Piva R; Penolazzi L; Lambertini E; Giordano S; Gambari R
    Apoptosis; 2005 Oct; 10(5):1079-94. PubMed ID: 16151641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of estrogen receptor α in bone-forming cells induces bone loss in female mice.
    Määttä JA; Büki KG; Gu G; Alanne MH; Vääräniemi J; Liljenbäck H; Poutanen M; Härkönen P; Väänänen K
    FASEB J; 2013 Feb; 27(2):478-88. PubMed ID: 23073829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoprotective Effects of Estrogen in the Maxillary Bone Depend on ERα.
    Macari S; Ajay Sharma L; Wyatt A; Knowles P; Szawka RE; Garlet GP; Grattan DR; Dias GJ; Silva TA
    J Dent Res; 2016 Jun; 95(6):689-96. PubMed ID: 26917440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of mitochondrial signaling pathways in the mechanism of Fas-mediated apoptosis after spinal cord injury.
    Yu WR; Liu T; Fehlings TK; Fehlings MG
    Eur J Neurosci; 2009 Jan; 29(1):114-31. PubMed ID: 19120440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoblast-induced osteoclast apoptosis by fas ligand/FAS pathway is required for maintenance of bone mass.
    Wang L; Liu S; Zhao Y; Liu D; Liu Y; Chen C; Karray S; Shi S; Jin Y
    Cell Death Differ; 2015 Oct; 22(10):1654-64. PubMed ID: 25744024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anabolic action of intermittent PTH in combination with cathepsin K inhibitor or alendronate differs depending on the remodeling status in bone in ovariectomized mice.
    Yamane H; Sakai A; Mori T; Tanaka S; Moridera K; Nakamura T
    Bone; 2009 Jun; 44(6):1055-62. PubMed ID: 19303837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone prevents orchidectomy-induced bone loss in estrogen receptor-alpha knockout mice.
    Vandenput L; Ederveen AG; Erben RG; Stahr K; Swinnen JV; Van Herck E; Verstuyf A; Boonen S; Bouillon R; Vanderschueren D
    Biochem Biophys Res Commun; 2001 Jul; 285(1):70-6. PubMed ID: 11437374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The estrogen receptor-alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone.
    Martin-Millan M; Almeida M; Ambrogini E; Han L; Zhao H; Weinstein RS; Jilka RL; O'Brien CA; Manolagas SC
    Mol Endocrinol; 2010 Feb; 24(2):323-34. PubMed ID: 20053716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor alpha-induced cholecystokinin type A receptor expression in the female mouse pituitary.
    Kim HJ; Gieske MC; Hudgins S; Kim BG; Krust A; Chambon P; Ko C
    J Endocrinol; 2007 Dec; 195(3):393-405. PubMed ID: 18000302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cathepsin K deficiency partially inhibits, but does not prevent, bone destruction in human tumor necrosis factor-transgenic mice.
    Schurigt U; Hummel KM; Petrow PK; Gajda M; Stöckigt R; Middel P; Zwerina J; Janik T; Bernhardt R; Schüler S; Scharnweber D; Beckmann F; Saftig P; Kollias G; Schett G; Wiederanders B; Bräuer R
    Arthritis Rheum; 2008 Feb; 58(2):422-34. PubMed ID: 18240253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.